ABEOME CORP has a total of 21 patent applications. It decreased the IP activity by 88.0%. Its first patent ever was published in 2002. It filed its patents most often in Australia, United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are STATEN BIOTECHNOLOGY B V, ARGENX BVBA and SYMPHOGEN A.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 3 | |
#2 | United States | 3 | |
#3 | WIPO (World Intellectual Property Organization) | 3 | |
#4 | Canada | 2 | |
#5 | China | 2 | |
#6 | EPO (European Patent Office) | 2 | |
#7 | Israel | 2 | |
#8 | Republic of Korea | 2 | |
#9 | Brazil | 1 | |
#10 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Agriculture |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Analysing materials | |
#5 | Microorganisms | |
#6 | Animal care |
# | Name | Total Patents |
---|---|---|
#1 | Vincent Thomas | 15 |
#2 | Jackson Crystal | 8 |
#3 | Shimkets Richard | 8 |
#4 | Shimkets Richard A | 8 |
#5 | Bartlett Nathan | 7 |
#6 | Luo Yonghua | 7 |
#7 | Jackson Crystal Lyles | 7 |
#8 | Laterza Vince | 2 |
#9 | Meagher Richard B | 2 |
#10 | Crystal Lyles Jackson | 2 |
Publication | Filing date | Title |
---|---|---|
US2021017284A1 | High affinity neutralizing monoclonal antibodies to programmed death ligand 1 (pd-l1) and uses thereof | |
KR20190039469A | Neutralizing monoclonal antibodies against IL-25 and uses thereof | |
WO2012142590A2 | Antibody generation from plasmacytoma-prone transgenic animals | |
AU2002253981B2 | Rapid production of monoclonal antibodies |